TMDX

TransMedics Group
TMDX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$3.12B
EV
$3.30B
Shares Outstanding
35.43M
Beta
2.13

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$103.14
P/E 2025E
61.31x
P/Revenue 2025E
5.77x

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About TransMedics Group, Inc.

gainify
TMDX

TransMedics Group, Inc.

TMDX

TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusi...

Sector

Healthcare

Industry

Medical - Devices

CEO

Hassanein, Waleed

Employees

728

IPO Date

2019-05-02

Headquarters

200 Minuteman Road, Suite 302, Andover, Massachusetts, 01810, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved